National Conference on Drug Abuse Research & Practice, an alliance for the 21st century : January 12-15, 1991, Grand Hyatt Washington, Washington, D.C. : Conference Highlights PDF
Preview National Conference on Drug Abuse Research & Practice, an alliance for the 21st century : January 12-15, 1991, Grand Hyatt Washington, Washington, D.C. : Conference Highlights
NationalInstituteonDrugAbuse NATIONALCONFERENCE ANALLIANCE ONDRUGABUSE FORTHE RESEARCH&PRACTICE ZlstCENTURY January12-15,1991•GrandHyattWashington•Washington,D.C. CONFERENCE HIGHLIGHTS U.S.DEPARTMENTOFHEALTHANDHUMANSERVICES / PublicHealthService \ Alcohol,DrugAbuse,andMentalHealthAdministration \ ! Wf A A A A A A A A A A A A A A A A A A A A A A A A A A | A A A A i: A A A A A A A A A A A A 1 A A A A A A a: • A ! A A 1 National Institute on Drug Abuse National Conference on Drug Abuse Research & Practice: An Alliance for the 21st Century January 12-15, 1991 Grand Hyatt Washington Washington, D.C. Conference Highlights U.S. Department of Health and Human Services Public Health Service Alcohol, Drug Abuse, and Mental Health Administration Officeof Policyand ExternalAffairs Communityand Professional Education 5600 FishersLane Rockville, MD 20857 ThispublicationwaspreparedfortheCommunityandProfessionalEducation Branch,OfficeofPolicyandExternalAffairs,NationalInstituteonDrugAbuse byCSR, IncorporatedunderContract No. 271-90-2205. PublicDomain Notice All materialappearing inthisvolume is inthepublicdomainandmaybe reproducedorcopiedwithoutpermission.Citationofthesourceisappreciated. Disclaimer Theopinionsexpressedinthisvolumearethoseoftheauthorsanddonot necessarily reflect the opinions orofficial policy of the National Institute on Drug Abuse oranyotherpartofthe U.S. Departmentof Health and Human Services. The U.S.Governmentdoesnotendorseorfavoranyspecificcommercial productorcompany. Trade,proprietary,orcompanynamesappearinginthis publicationareusedonlybecausetheyareconsideredessentialinthecontext ofthe material reported herein. DHHS Publication No. (ADM) 91-1818 Printed 1991 DEPARTMENT OF HEALTH & HUMAN SERVICES DearColleague: TheseproceedingsarethehighlightsoftheNationalInstituteonDrugAbuse’s (NIDA)firstNationalConferenceonDrugAbuseResearch&Practice: An Allianceforthe21stCentury. Theconferencewasdesignedspecificallyto promotetheexchangeofinformationamongdrugabuseresearchers,community practitioners,andprogramadministrators. Theoverwhelmingsuccessofthe conferencepromptedustopublishtheseproceedingstosupplementthedialogue initiatedattheconference. Includedinthehighlightsaresummariesofthe workshops,forums,dinnerspeeches,andplenarysessionsthatwerepresented duringthe4daysoftheconferenceheldJanuary 12through 15, 1991. NIDAhasconductedandsupportedresearchsince 1974whenitwasestablished asanInstituteoftheAlcohol,DrugAbuse,andMentalHealthAdministration withintheDepartmentofHealthandHumanServices. NIDA’sscientificresearch hasenabledustobuildabroad,dependablebaseofinformationonhowdrugs affectindividuals. Wearelearningaboutthebiological,behavioral, social,and environmentalinfluencesthatplaceindividualsatriskfordrugabuseand dependenceandstrategiesforpreventingandtreatingthesedisorders. Itisimportantthattheresearchfindingspresentedattheconferenceand summarizedinthesehighlightsbebroughttotheattentionofresearchers, practitioners,andadministratorswhocanpromotetheirapplicationtotreatment andpreventionprograms. ThisisonemoredemonstrationofNIDA’scommitment tobuildinganalliancebetweenthedrugabuseresearcherandpractitioner. Ihopetheseproceedingsserveasausefulresourcetoyou. Sincerely, Director,NationalInstituteonDrugAbuse . Contents Summariesof Plenary Sessions 1 Epidemiology 1 Charles R. Schuster, Ph.D 1 EnochGordis, M.D 2 Treatment 4 Alan I. Leshner, Ph.D 4 Beny Primm, M.D 4 Prevention 5 Charles R. Schuster, Ph.D 5 Elaine M. Johnson, Ph.D 6 Drugs intheWorkplace 7 Charles R. Schuster, Ph.D 7 J. MichaelWalsh, Ph.D 7 MarkJ. Barnes, J.D 8 AIDSandSubstanceAbuse 9 HarryW. Haverkos, M.D 9 SummariesofWorkshops 11 1.01 OverviewofAssessmentand DiagnosticTools 11 1.02 Administering and InterpretingAssessmentTools 13 1.03 Treatment ProgramSelf-Evaluation 15 1.04 Models and MethodsforPatientMatching 18 1.05 Overcoming Barriersto DrugAbuseTreatment 20 1.06 Retention in DrugTreatment: WhatArethe Retention Ratesand WhoArethe Dropouts? 22 1.07 Retention in DrugTreatment: WhatArethe Reasonsfor Dropouts and HowCan We Improve Retention? 24 1.08 Psychotherapeutic Interventions 27 1.10 TheSelf-HelpModality: AA, NA, andOtherSelf-Help Groups 29 1.11 Effectivenessof FamilyTherapy: Outcome Research 31 1.12 StrategiesforBreaking Marijuana Dependence 33 1.13 InterventionsforCigaretteSmoking 35 1.14 Medicaland PhysiologicalAspectsofMethadone MaintenanceTreatment 36 1.15 ContingencyContracting 38 1.16 Treatmentof Multiple Drug Use inaMethadone MaintenanceSetting 41 v NIDAConference Highlights 1.17 PharmacologicalAdvances in DrugAbuseTreatment: PartA 44 1.18 PharmacologicalAdvances in DrugAbuseTreatment: Part B 47 1.19 TheTreatmentofCocaineAbuse: BehavioralApproaches ... 50 1.20 TheTreatmentofCocaineAbuse: PsychosocialTreatment ... 53 1.21 Relapse PreventionThroughSkillsTraining 55 1.22 Vocational Rehabilitation/Employment Development 57 1.23 AddictAftercare Manual 59 1.24 Identificationof Dual Diagnosisin DrugAbusers 61 1.25 AppropriateTreatmentServicesforDual Diagnosis in DrugAbusers 64 1.26 Intakeand Diagnosisof Drug-DependentWomen 67 1.27 Intakeand Diagnosisof Drug-Dependent Pregnantand PostpartumWomen 68 1.28 TreatmentforPregnantand PostpartumWomenand TheirInfants 71 1.29 Residential ProgramsforWomen 74 1.30 Drug-ExposedYoungChildren 77 1.31 AdolescentScreeningand DiagnosticAssessmentTools 79 1.32 FamilyTherapyforDrug-AbusingAdolescents 81 1.33 Drug AbuseTreatment ModelsforPrison Populations 83 2.01 OverviewofComprehensive Drug Prevention Programs 86 2.02 The Roleof Research Informationin Preventionand Public Education 87 2.03 Evaluatingthe EfficacyofDrug Prevention Programs 89 2.04 Drug Abuse Preventionandthe Media 91 2.05 Riskand Protective FactorsforAdolescent Drug Use andAbuse 93 2.06 PreventionforHigh-RiskYouth 96 2.07 Parent Education Programs 99 2.08 Drug EducationCurricula—Exemplary Programs 100 3.01 NIDA DrugAbuseandAIDSCommunity Education Programs 102 3.02 ImplementationofAIDS PreventionCommunity Programs ... 104 3.03 AIDSintheWorkplace: Systems Interventions 106 3.04 PreventionofHIV InfectionandAIDSAmong DrugAbusers . . 108 3.05 Infectious Diseasesand HIV DrugAbusers 110 3.06 PsychosocialAspectsofAIDSand DrugAbuseClients 112 3.07 Counseling and PsychotherapeuticApproachesto Issues Relatedto HIVandAIDS in DrugAbusers 113 3.08 HIVTestinginTreatment 114 3.09 AIDSand Risk Reduction in DrugAbuseTreatmentSettings . 116 3.10 AIDS Risksin Pregnant Intravenous Drug Usersand TheirChildren 118 3.11 AService DeliverySystemModelforAIDS Prevention forWomen 119 vi Contents 3.12 Outreach Progr—amsforIntravenous Drug Users 121 3.13 AIDSOutreach BehaviorChangeStrategies 124 3.14 StrategiesforCoordinationofCare 125 4.01 Researchon Drugs intheWorkplace: Assessingthe Natureand Extentof Drug Useand Its Impact 127 4.02 Researchon Drugs intheWorkplace: Drug-Free Workplace Programs 131 4.03 Establishing Procedures and PoliciesforEmployee DrugTesting 135 4.04 Policy DevelopmentConcernsToAchieveaWorkplace Freeof Drugs 140 Summariesof Issue Forums 145 5.01 Drug AbuseTreatmentforAfricanAmericans 145 5.02 Drug AbuseTreatmentforHispanicAmericans 147 5.03 Drug/AlcoholAbuseTreatmentforNativeAmericans 149 5.04 Drug AbuseTreatmentforAsianAmericans 151 5.05 TreatmentofGayand Lesbian DrugAbusers 153 5.06 Drug AbuseTreatment inCorrectional Settings 155 5.07 SpecialServicesforWomen inTreatment 157 5.08 ChildhoodSexualTraumaandTreatmentofSubstanceAbusers159 5.09 Treatment Planning 161 5.10 Drug Abuse Funding andTreatment Resources 163 5.11 Overviewof Medications Development 166 5.12 Staff Burnout Issues 168 5.13 Drug Abuse PreventionforAfricanAmericans 170 5.14 Drug Abuse PreventionforHispanicAmericans 172 5.15 Drug Abuse PreventionforNativeAmericans 174 5.16 Drug Abuse PreventionforAsian Americans 177 5.17 AnabolicSteroidsandOtherPerformance-Enhancing Drugs . . 179 5.18 DrugAbuse andAIDS: Interventions inAfrican American Populations 181 5.19 Drug Abuse andAIDS: Interventionsin HispanicAmerican Populations 183 5.20 Drug Abuse andAIDS: Interventions in Native American Populations 186 5.21 DrugAbuse andAIDS: Interventions inAsian American Populations 189 5.22 DrugAbuseTraining Resources 191 5.23 Alcoholand DrugTreatment DataCollectionSystems 194 5.24 Community-Based EpidemiologyWorkgroups 196 5.25 NIDA DataCollectionSystems 199 5.26 Drug-Free Workplace Programs—Essential Elements and Critical Issues 202 vii NIDAConference Highlights 5.27 FacilitatingCommunicationBetween Researchersand Community-Based Programs 204 5.28 RuralAlcoholand DrugAbuse Programs 208 5.29 Legislative Issuesin DrugAbuse 211 5.30 How Can Improved Science Education HelpinAchieving PreventionandTreatmentGoals? 213 5.32 AfricanAmericanWomenandHIV/AIDS 215 PosterSessions 219 Roundtable Issues Luncheon 223 SummariesofSpecialWorkshops 227 8.01 Securing Funding. PartA: Public 227 8.02 Securing Funding. PartB: Private 230 Conference Dinner 233 Presentationofthe1991 PacesetterAwards 237 Directoryof Speakers 239 viii
The list of books you might like
